Home » Stocks » APOP

Cellect Biotechnology Ltd. (APOP)

Stock Price: $2.41 USD 0.06 (2.55%)
Updated Apr 23, 2021 9:57 AM EDT - Market open
Market Cap 8.84M
Revenue (ttm) n/a
Net Income (ttm) -5.65M
Shares Out 3.91M
EPS (ttm) -0.85
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day April 23
Last Price $2.41
Previous Close $2.35
Change ($) 0.06
Change (%) 2.55%
Day's Open 2.35
Day's Range 2.35 - 2.50
Day's Volume 9,046
52-Week Range 1.65 - 7.15

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

Cellect Biotechnology Ltd (NASDAQ: APOP) has announced data from the Phase 1/2 study in Israel evaluating ApoGraft technology for Graft versus Host Disease (GvHD), a severe complication of allogeneic he...

3 days ago - Benzinga

TEL AVIV, Israel, March 29, 2021 (GLOBE NEWSWIRE) -- Cellect Biotechnology Ltd. (NASDAQ: “APOP”), a developer of innovative technology that enables the functional selection of stem cells, today reported...

3 weeks ago - GlobeNewsWire

Cellect Biotechnology Ltd. (NASDAQ: APOP), Immutep Limited (NASDAQ: IMMP), F-star Therapeutics, Inc. (NASDAQ: FSTX), ProQR Therapeutics N.V.

Other stocks mentioned: EVFM, FSTX, IMMP, PRQR
4 weeks ago - Benzinga

ProQR Therapeutics NV (NASDAQ: PRQR) shares are trading higher by more than 52% after the company reported results Wednesday from its trial of QR-421a in Usher Syndrome, though the stock did not surge i...

Other stocks mentioned: PRQR
4 weeks ago - Benzinga

APOP stock holders are getting a 1:3 ratio of shares in the tie-up deal. The merger brings together Cellect's stem cell tech with Quoin's rare and orphan diseases focus.

4 weeks ago - InvestorPlace

Pre-market movers this morning include some high-profile top gainers and losers. Take a look at this list that includes NFT stocks and EV plays.

Other stocks mentioned: CIDM, CNET, CSCW, ENOB, NGA, OGEN, SGOC ...
4 weeks ago - InvestorPlace

Up to $25 million of funding at $75 million pre-money valuation to be available to the combined company concurrently with the merger

4 weeks ago - GlobeNewsWire

Promising Progress on Clinical D evelopment Progress , Collaboration s and Partnering

5 months ago - GlobeNewsWire

Tel Aviv, Israel , Oct. 22, 2020 (GLOBE NEWSWIRE) -- Cellect Biotechnology Ltd. (NASDAQ: "APOP"), a developer of innovative technology which enables the functional selection of cells facilitating safer ...

6 months ago - GlobeNewsWire

Management to Highlight Progress in Bone Marrow Transplant (BMT) and Chimeric Antigen Receptor T Cell (CAR T) Business Collaborations

7 months ago - GlobeNewsWire

TEL AVIV, Israel, Aug. 12, 2020 /PRNewswire/ -- Cellect Biotechnology Ltd.

8 months ago - PRNewsWire

TEL AVIV, Israel, May 21, 2020 /PRNewswire/ -- Cellect Biotechnology Ltd. (NASDAQ: APOP), a developer of innovative technology which enables the functional selection of stem cells, today reported financ...

11 months ago - PRNewsWire

TEL AVIV, Israel, May 21, 2020 (GLOBE NEWSWIRE) -- Cellect Biotechnology Ltd. (NASDAQ: "APOP"), a developer of innovative technology which enables the functional selection of stem cells, today reporte...

11 months ago - GlobeNewsWire

TEL AVIV, Israel, May 12, 2020 (GLOBE NEWSWIRE) -- Cellect Biotechnology Ltd. (NASDAQ: APOP), a developer of innovative technology which enables the functional selection of stem cells, today announced...

11 months ago - GlobeNewsWire

Cellect Biotechnology Ltd. (NASDAQ: APOP) shares nearly doubled to start the week after the company announced progress with its bone marrow transplantation process.

11 months ago - 24/7 Wall Street

Shares of thinly-traded nano-cap biotech Cellect Biotechnology Ltd – ADR (NASDAQ: APOP) are advancing strongly Wednesday.

1 year ago - Benzinga

Cellect Biotechnology (APOP) news for Tuesday includes new patent approvals overseas that have APOP stock soaring higher. The post Cellect Biotechnology News: APOP Stock Rockets 76% on New Patent Approv...

1 year ago - InvestorPlace

Cellect Biotechnology Ltd – ADR (NASDAQ: APOP) shares are more than doubling following an announcement concerning patents in two regions.

1 year ago - Benzinga

The thinly traded nano-cap penny stock CELLECT BIOTECH/S ADR (NASDAQ: APOP) was soaring Monday.

1 year ago - Benzinga

About APOP

Cellect Biotechnology Ltd., a biotechnology company, engages in developing ApoGraft, a technology platform that functionally selects stem cells to enhance the safety of regenerative medicine and stem cell therapies in Israel. The company develops ApoTainer, a kit for hematopoietic stem cell transplantation procedures. It has collaborations with the denovoMATRIX group of the Technische Universität Dresden to conduct examinations into the tentative synergy between ApoGraft and denovoMAtrix technology for the purpose of evaluating collaborative d... [Read more...]

Industry
Biotechnology
Founded
2011
CEO
Shai Yarkoni
Employees
12
Stock Exchange
NASDAQ
Ticker Symbol
APOP
Full Company Profile

Financial Performance

Financial numbers in millions ILS.
Financial Statements